Clinical benefits of natriuretic peptides and galectin-3 are maintained in old dyspnoeic patients.
Sign Up to like & getrecommendations! Published in 2017 at "Archives of gerontology and geriatrics"
DOI: 10.1016/j.archger.2016.08.010
Abstract: BACKGROUND Acute dyspnoea is the leading cause of unscheduled admission of elderly patients. Several biomarkers are used to diagnose acute heart failure (AHF) and assess prognosis of dyspnoeic patients, but their value in elderly patients… read more here.
Keywords: clinical benefits; old dyspnoeic; auc; dyspnoeic patients ... See more keywords